GPN2 Antisense RNA 1 (GPN2-AS1)

GPN2 Antisense RNA 1 (GPN2-AS1) is a long non-coding RNA transcribed from the opposite DNA strand of the GPN2 gene; it is characterized as an antisense transcript, which typically functions to regulate the expression of its sense gene through RNA-RNA interactions, chromatin modification, or stability of target transcripts[1][2][5]. Like other antisense lncRNAs, GPN2-AS1 does not encode for a protein but may influence gene expression by forming duplexes with its sense transcript, interfering with translation, modifying epigenetic state, or altering RNA half-life. However, specific biological roles, disease associations, or targeting strategies for GPN2-AS1 have not been identified in current literature[2][5]. There are no alternative names in use and no evidence that this molecule is a therapeutic target; it fits the classification of antisense long non-coding RNA. Its canonical abbreviation is "GPN2-AS1." Functions and disease associations are inferred from general knowledge about similar antisense lncRNAs, not specific studies of GPN2-AS1 itself[1][2][5].

Not applicable; since there are no known drugs targeting GPN2-AS1.